Edition:
United States

Protalix Biotherapeutics Inc (PLX.TA)

PLX.TA on Tel Aviv Stock Exchange

365.50ILa
27 Apr 2017
Change (% chg)

-3.70 (-1.00%)
Prev Close
369.20
Open
363.00
Day's High
388.00
Day's Low
363.00
Volume
571,068
Avg. Vol
1,114,316
52-wk High
549.00
52-wk Low
110.50

PLX.TA

Chart for PLX.TA

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.13
Market Cap(Mil.): ₪450.38
Shares Outstanding(Mil.): 124.13
Dividend: --
Yield (%): --

Financials

  PLX.TA Industry Sector
P/E (TTM): -- 58.07 30.12
EPS (TTM): -1.06 -- --
ROI: -57.18 0.23 13.28
ROE: -6,370.31 6.18 14.44

More From Around the Web

Earnings vs. Estimates